{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:11:22Z","timestamp":1777860682324,"version":"3.51.4"},"reference-count":42,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"4","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Rheumatology"],"abstract":"<jats:p>Objectives: This study aimed to evaluate the performance of the Beh\u00e7et\u2019s Syndrome Overall Damage Index (BODI) in an adult Egyptian cohort.\r\nPatients and methods: This longitudinal retrospective cohort study included 282 adult patients (233 males, 49 females; mean age: 35.3\u00b18.7 years; range, 16 to 66 years) with Beh\u00e7et\u2019s disease (BD) between January 1980 and December 2022. BODI was assessed regarding construct validity, sensitivity to change, and intra- and inter-rater reliability. The ability of BODI to discriminate between activity and damage was evaluated. Its performance in another vasculitis syndrome was assessed in 12 patients with antineutrophil cytoplasmic antibody-associated vasculitis.\r\nResults: BODI captured more damage items compared to the Vasculitis Damage Index (VDI). BODI scores were not correlated with disease activity and had poor performance in other vasculitides. BODI had a trend of progressive increment over time. It showed consistence when reassessed by the same rater and by different raters. Some damage items in the study cohort were lacking in BODI.\r\nConclusion: BODI is more comprehensive compared to VDI. It shows good face, construct, and discriminant validity. It is sensitive to change and has good intra- and inter-rater reliability. Newer versions of BODI are recommended to increase score comprehensiveness.<\/jats:p>","DOI":"10.46497\/archrheumatol.2024.10893","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:56:27Z","timestamp":1740988587000},"page":"607-616","source":"Crossref","is-referenced-by-count":2,"title":["Beh\u00e7et\u2019s Syndrome Overall Damage Index performance and validation in an adult Egyptian cohort"],"prefix":"10.5152","volume":"39","author":[{"family":"Doaa Attia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lobna Maged","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3111","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11. doi: 10.1002\/art.37715.","DOI":"10.1002\/art.37715"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Hellmann DB. Giant cell arteritis, polymyalgia rheumatica and Takayasu\u2019s arteritis. In: Firestein GS, Budd RC, Gabriel SE, Mcinnes LB, O'Dell JR, editors. Kelley & Firestein\u2019s textbook of rheumatology. 10th ed. Philadelphia: Elsevier; 2017. p. 1520-40.","DOI":"10.1016\/B978-0-323-31696-5.00088-7"},{"key":"ref-3","unstructured":"Mau W, Meran JG, Zeidler H. Concept and criteria of spondylarthritis. Wien Med Wochenschr 1990;140:334-8. German."},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Beh\u00e7et's disease. Autoimmun Rev 2012;11:687-98. doi: 10.1016\/j.autrev.2011.11.026.","DOI":"10.1016\/j.autrev.2011.11.026"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Azizlerli G, K\u00f6se AA, Sarica R, G\u00fcl A, Tutkun IT, Kula\u00e7 M, et al. Prevalence of Beh\u00e7et's disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-6. doi: 10.1046\/j.1365-4362.2003.01893.x.","DOI":"10.1046\/j.1365-4362.2003.01893.x"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Attia DHS, Abdel Noor RA, Salah S. Shedding light on vasculitis in Egypt: A multicenter retrospective cohort study of characteristics, management, and outcome. Clin Rheumatol 2019;38:1675-84. doi: 10.1007\/s10067-019-04441-4.","DOI":"10.1007\/s10067-019-04441-4"},{"key":"ref-7","unstructured":"Yavuz S, Ozilhan G, Elbir Y, Tolunay A, Eksioglu-Demiralp E, Direskeneli H. Activation of neutrophils by testosterone in Beh\u00e7et's disease. Clin Exp Rheumatol 2007;25(4 Suppl 45):S46-51."},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, et al. Beh\u00e7et's disease: Diagnostic and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103. doi: 10.1007\/ s004150170242.","DOI":"10.1007\/s004150170242"},{"key":"ref-9","unstructured":"Kaufman WS, McNamara EK, Jorizzo JL. Beh\u00e7et\u2019s disease. In: Firestein GS, Budd RC, Gabriel S E, Mcinnes LB and O'Dell JR, editors. Kelley & Firestein\u2019s textbook of rheumatology, 10th ed. Philadelphia: Elsevier; 2017. p. 1589-96."},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Carpenter DM, Thorpe CT, Lewis M, Devellis RF, Hogan SL. Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum 2009;61:259-65. doi: 10.1002\/art.24235.","DOI":"10.1002\/art.24235"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Fries JF, Hochberg MC, Medsger TA Jr, Hunder GG, Bombardier C. Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1994;37:454- 62. doi: 10.1002\/art.1780370403.","DOI":"10.1002\/art.1780370403"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-98. doi: 10.7326\/0003- 4819-116-6-488.","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Easley E, et al. Developing a core set of outcome measures for Beh\u00e7et Disease: Report from OMERACT 2016. J Rheumatol 2017;44:1750-3. doi: 10.3899\/jrheum.161352.","DOI":"10.3899\/jrheum.161352"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371- 80. doi: 10.1002\/art.1780400222.","DOI":"10.1002\/art.1780400222"},{"key":"ref-15","unstructured":"Seo P, Luqmani RA, Flossmann O, Hellmich B, Herlyn K, Hoffman GS, et al. The future of damage assessment in vasculitis. J Rheumatol 2007;34:1357-71."},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Piga M, Floris A, Espinosa G, Serpa Pinto L, Kougkas N, Lo Monaco A, et al. Development and preliminary validation of the Beh\u00e7et's syndrome Overall Damage Index (BODI). RMD Open 2020;6:e001192. doi: 10.1136\/rmdopen-2020-001192.","DOI":"10.1136\/rmdopen-2020-001192"},{"key":"ref-17","unstructured":"Watts RA. Epidemiology of vasculitis in Indiawhat is known? Indian Rheumatology Association. 2005;13:6-13."},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Leonardo NM, McNeil J. Behcet's Disease: Is there geographical variation? A review far from the Silk  Road. Int J Rheumatol 2015;2015:945262. doi: 10.1155\/2015\/945262.","DOI":"10.1155\/2015\/945262"},{"key":"ref-19","unstructured":"Joshi VR, Mittal G. Vasculitis--Indian perspective. J Assoc Physicians India 2006;54 Suppl:12-4."},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet's disease: From East to West. Clin Rheumatol 2010;29:823-33. doi: 10.1007\/s10067-010-1430-6.","DOI":"10.1007\/s10067-010-1430-6"},{"key":"ref-21","doi-asserted-by":"crossref","unstructured":"Ames PR, Steuer A, Pap A, Denman AM. Thrombosis in Beh\u00e7et's disease: A retrospective survey from a single UK centre. Rheumatology (Oxford) 2001;40:652-5. doi: 10.1093\/rheumatology\/40.6.652.","DOI":"10.1093\/rheumatology\/40.6.652"},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Joseph FG, Scolding NJ. Neuro-Beh\u00e7et's disease in Caucasians: A study of 22 patients. Eur J Neurol 2007;14:174-80. doi: 10.1111\/j.1468- 1331.2006.01613.x.","DOI":"10.1111\/j.1468-1331.2006.01613.x"},{"key":"ref-23","unstructured":"Davatchi F, Schirmer M, Zouboulis C, Assad-Khalil S, Calamia KT. On behalf of the International Team for the Revision of the International Study Group Criteria for Bechet's disease. Evaluation and Revision of the International Study Group Criteria for Behcet's disease. Proceedings of the American College of Rheumatology Meeting; November 2007; Boston, MA. Abstract 1233."},{"key":"ref-24","unstructured":"International Society for Beh\u00e7et\u2019s Disease. Beh\u00e7et\u2019s Disease Current Activity Form 2006, 2006. Available at: https:\/\/behcetdiseasesociety.org\/behcetwsData\/ Uploads\/files\/BehcetsDiseaseActivityForm.pdf. [Accessed: 02.01.2023]."},{"key":"ref-25","doi-asserted-by":"crossref","unstructured":"Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Beh\u00e7et's disease: Evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 1999;38:728-33. doi: 10.1093\/rheumatology\/38.8.728.","DOI":"10.1093\/rheumatology\/38.8.728"},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7. doi: 10.1002\/art.1780330807.","DOI":"10.1002\/art.1780330807"},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100. doi: 10.1002\/art.1780330806.","DOI":"10.1002\/art.1780330806"},{"key":"ref-28","unstructured":"Shehab D, al-Jarallah K, Moussa MA. Validation of the Arabic version of the Health Assessment Questionnaire (HAQ) in patients with rheumatoid arthritis. Rev Rhum Engl Ed 1998;65:387-92."},{"key":"ref-29","unstructured":"Alabdulmohsin SA, Coons SJ, Draugais SJ, Hays RD. Translation of the RAND 36-Health Survey 1.0 (aka SF-36) into Arabic. Santa Monica, CA: RAND; 1997. p. 7995, Available at: https:\/\/www.rand.org\/ health\/surveys_tools\/mos\/36-itemshort-form.html [Accessed: 28.03.2018]."},{"key":"ref-30","unstructured":"Naing L, Winn T and Rusli BN. Sample Size Calculator for Prevalence Studies, 2006. Available at: https:\/\/ www.researchgate.net\/profile\/Jawad_Abbas3\/post\/ Do_you_know_any_sample_size_calculation_for_ non_probability_quota_sampling_technique\/attac hment\/5a626e09b53d2f0bba4c7617\/AS%3A584 638703611904%401516400137358\/download\/ Sample+Size+Calculator.xls. [Accessed: 08.01.2022]"},{"key":"ref-31","doi-asserted-by":"crossref","unstructured":"Nelson CA, Stephen S, Ashchyan HJ, James WD, Micheletti RG, Rosenbach M. Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Beh\u00e7et disease. J Am Acad Dermatol 2018;79:987-1006. doi: 10.1016\/j.jaad.2017.11.064.","DOI":"10.1016\/j.jaad.2017.11.064"},{"key":"ref-32","doi-asserted-by":"crossref","unstructured":"Zaj\u0105c H, Turno-Kr\u0119cicka A. Ocular manifestations of Beh\u00e7et's Disease: An update on diagnostic challenges and disease management. J Clin Med 2021;10:5174. doi: 10.3390\/jcm10215174.","DOI":"10.3390\/jcm10215174"},{"key":"ref-33","doi-asserted-by":"crossref","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Beh\u00e7et syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60-76. doi: 10.1097\/00005792-200301000-00006.","DOI":"10.1097\/00005792-200301000-00006"},{"key":"ref-34","doi-asserted-by":"crossref","unstructured":"Nowak MS, Smigielski J. The prevalence and causes of visual impairment and blindness among older adults in the city of Lodz, Poland. Medicine (Baltimore) 2015;94:e505. doi: 10.1097\/ MD.0000000000000505.","DOI":"10.1097\/MD.0000000000000505"},{"key":"ref-35","doi-asserted-by":"crossref","unstructured":"Al-Araji A, Kidd DP. Neuro-Beh\u00e7et's disease: Epidemiology, clinical characteristics, and management. Lancet Neurol 2009;8:192-204. doi: 10.1016\/S1474-4422(09)70015-8.","DOI":"10.1016\/S1474-4422(09)70015-8"},{"key":"ref-36","doi-asserted-by":"crossref","unstructured":"Seyahi E, Yurdakul S. Beh\u00e7et's syndrome and thrombosis. Mediterr J Hematol Infect Dis 2011;3:e2011026. doi: 10.4084\/MJHID.2011.026.","DOI":"10.4084\/mjhid.2011.026"},{"key":"ref-37","doi-asserted-by":"crossref","unstructured":"Yurdakul S, T\u00fcz\u00fcner N, Yurdakul I, Hamuryudan V, Yazici H. Gastrointestinal involvement in Beh\u00e7et's syndrome: A controlled study. Ann Rheum Dis 1996;55:208-10. doi: 10.1136\/ard.55.3.208.","DOI":"10.1136\/ard.55.3.208"},{"key":"ref-38","doi-asserted-by":"crossref","unstructured":"Hirahara L, Kirino Y, Soejima Y, Iizuka Y, Yoshimi R, Fujieda Y, et al. Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in Beh\u00e7et disease: A prospective registry study. Front Immunol 2024;15:1354969. doi: 10.3389\/fimmu.2024.1354969.","DOI":"10.3389\/fimmu.2024.1354969"},{"key":"ref-39","doi-asserted-by":"crossref","unstructured":"Akpolat T, Dilek M, Aksu K, Keser G, Toprak O, Cirit M, et al. Renal Beh\u00e7et's disease: An update. Semin Arthritis Rheum 2008;38:241-8. doi: 10.1016\/j. semarthrit.2007.11.001.","DOI":"10.1016\/j.semarthrit.2007.11.001"},{"key":"ref-40","doi-asserted-by":"crossref","unstructured":"Ozogul YY, Ozguler Y, Esatoglu SN, Ucar D, Uygunoglu U, Kutlubay Z, et al. Validation of the Beh\u00e7et's Syndrome Overall Damage Index (BODI) for Retrospective studies and a proposal for modification. Rheumatology (Oxford) 2024:keae266. doi: 10.1093\/ rheumatology\/keae266.","DOI":"10.1093\/rheumatology\/keae266"},{"key":"ref-41","doi-asserted-by":"crossref","unstructured":"Musavian S, Farzaneh R, Rahimi M, Mahdavi AM, Gojazadeh M, Khabbazi A. Validity and reliability of the BODI for assessing damage in Behcet's disease. Ir J Med Sci 2023;192:2549-53. doi: 10.1007\/s11845- 022-03260-y.","DOI":"10.1007\/s11845-022-03260-y"},{"key":"ref-42","doi-asserted-by":"crossref","unstructured":"Hassan RA, Abdelhady EI, Rabie M, Kamal DE. Damage accrual in Beh\u00e7et disease: Beh\u00e7et's Syndrome Overall Damage Index (BODI) versus Beh\u00e7et's Disease Damage Index (BDI). Int J Rheum Dis 2023;26:1103- 10. doi: 10.1111\/1756-185X.14705.","DOI":"10.1111\/1756-185X.14705"}],"container-title":["Archives of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1453\/2598","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1453\/2599","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1453\/2598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:00:43Z","timestamp":1761210043000},"score":1,"resource":{"primary":{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/view\/1453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,31]]}},"URL":"https:\/\/doi.org\/10.46497\/archrheumatol.2024.10893","relation":{},"ISSN":["2618-6500"],"issn-type":[{"value":"2618-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}